| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/08/2000 | WO2000051613A1 Upper hitch link |
| 09/08/2000 | WO2000051612A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051611A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051595A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | WO2000051567A1 Processes for making pharmaceutical oral ecb formulations and compositions |
| 09/08/2000 | WO2000051564A1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 09/08/2000 | WO2000051547A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000034260A3 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000023592B1 Minimal promoters and uses thereof |
| 09/08/2000 | WO2000019206A9 Ykl-40 as a marker and prognostic indicator for cancers |
| 09/08/2000 | WO2000016756A3 Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors |
| 09/08/2000 | WO2000015853A9 Recombinant newcastle disease virus rna expression systems and vaccines |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000004921A9 Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine |
| 09/08/2000 | CA2364415A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | CA2364006A1 Polymer compositions for polynucleotide delivery |
| 09/08/2000 | CA2363982A1 Pharmaceutical combination of antiviral agents |
| 09/08/2000 | CA2363169A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362840A1 Antibodies against phosphomannan that are protective against candidiasis |
| 09/08/2000 | CA2362804A1 Crystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s- 2,8- diazabicyclo- [4.3.0] nonan-8-yl) -6-fluoro -1,4-dihydro -4-oxo -3-quinoline carboxylic acid |
| 09/08/2000 | CA2362801A1 Crystal modification c of 8-cyano-1-cyclopropyl-7-(1s, 6s-2,8- diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362566A1 Modulators of fgl2 prothrombinase |
| 09/08/2000 | CA2362495A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | CA2362494A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362489A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | CA2362482A1 Processes for making pharmaceutical oral ecb formulations and compositions |
| 09/08/2000 | CA2362016A1 Echinocandin/carbohydrate complexes |
| 09/07/2000 | DE19912706A1 New staphylococcal DNA for dltABCD operons, useful e.g. for identifying antibacterials and agents that reduce bacterial resistance to antimicrobials |
| 09/07/2000 | DE19860438C1 Verfahren zur Herstellung von Autovakzinen zur Behandlung von Chlamydiosen von Säugetieren und Menschen A process for the production of vaccines for the treatment of auto chlamydioses of mammals and humans |
| 09/06/2000 | EP1033369A1 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 09/06/2000 | EP1033135A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens |
| 09/06/2000 | EP1033129A1 Antimicrobials |
| 09/06/2000 | EP1033128A2 Soft gelatin capsule manufacture |
| 09/06/2000 | EP1032682A1 Desaturase genes and their use |
| 09/06/2000 | EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032675A1 Attaching substances to micro-organisms |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032596A1 Lactalbumin production process |
| 09/06/2000 | EP1032592A1 Antimicrobial peptides |
| 09/06/2000 | EP1032591A1 NOVEL pth |
| 09/06/2000 | EP1032582A1 NOVEL recJ |
| 09/06/2000 | EP1032581A1 Chemical synthesis of 6-o-alkyl erythromycin a |
| 09/06/2000 | EP1032580A1 Process for n-desmethylating erythromycins and derivatives thereof |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP1032431A2 Medical article with adhered antimicrobial metal |
| 09/06/2000 | EP1032421A1 Monoclonal human natural antibodies |
| 09/06/2000 | EP1032420A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 09/06/2000 | EP1032417A1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 09/06/2000 | EP1032412A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells |
| 09/06/2000 | EP1032409A1 Herbal extract composition and method with immune-boosting capability |
| 09/06/2000 | EP1032388A1 Novel metal complexes |
| 09/06/2000 | EP1032387A1 Novel metal complexes |
| 09/06/2000 | EP1032384A1 Carbapenem antibacterial compounds, compositions and methods of treatment |
| 09/06/2000 | EP1032383A1 Antibacterial carbapenems, compositions and methods of treatmemt |
| 09/06/2000 | EP1032265A1 New psoralens for pathogen inactivation |
| 09/06/2000 | EP0901379B1 Type-2 chemokine binding proteins and methods of use therefor |
| 09/06/2000 | EP0697864B1 Use of ferrioxamine b in the treatment os septic shock |
| 09/06/2000 | EP0661974B1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin |
| 09/06/2000 | EP0593766B1 Pyridonecarboxylic acid derivative |
| 09/06/2000 | CN1265671A Alatrofloxacin parenteral compositions |
| 09/06/2000 | CN1265665A Benzimidazole derivatives |
| 09/06/2000 | CN1265659A Substituted cyclobutylamine derivatives |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265597A Composition comprising propolis and at least an essential oil |
| 09/06/2000 | CN1265594A Method for treating mastitis in domestic animal using rifamycin derivative |
| 09/06/2000 | CN1265590A Substituted alkanohydroxamic acid and method of reducing TNF 'alpha' levels |
| 09/06/2000 | CN1265564A Method for administering viable microorganism composition for poultry |
| 09/06/2000 | CN1265393A Process for preparing N-(amino-4,6-dihalopyrimidine) formamide |
| 09/06/2000 | CN1265326A Triple live chicken vaccine and its production process |
| 09/06/2000 | CN1265313A Dermatosis treating medicine |
| 09/06/2000 | CN1056145C Prepn. of 1,3-oxathiolane nucleoside analogue medicine composition |
| 09/06/2000 | CN1056068C Red sage root use for antivirus of AIDS and hepatitis B |
| 09/06/2000 | CN1056059C Prescription for curing gonorrhea and its preparing process |
| 09/06/2000 | CN1056058C Prep. of pharmaceutical formulation |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114517 Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules |
| 09/05/2000 | US6114389 Use of a pharmaceutically acceptable oxalate derivative for the treatment of skin conditions |
| 09/05/2000 | US6114388 Monofunctional and/or polyfunctional polylysine conjuages |
| 09/05/2000 | US6114377 For topical application, comprising an antimicrobial effective amount of 3-furancarboxylic acid combined with 2-furancarboxylic acid and optionally ferulic acid as an antiirritant; free of preservatives |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114357 Hemoregulatory compounds |
| 09/05/2000 | US6114351 N-oxides as antibacterial agents |
| 09/05/2000 | US6114349 Substituted quinoline derivatives with antiviral action |
| 09/05/2000 | US6114343 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)-1,3-oxathiolane |
| 09/05/2000 | US6114330 Substituted 2,4-diaminopyrimidines |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114327 Anti-viral compounds |
| 09/05/2000 | US6114316 Combination of bisphosphonate and tetracycline |
| 09/05/2000 | US6114309 Combinatorial library of moenomycin analogs and methods of producing same |
| 09/05/2000 | US6114131 Methods for the detection of antibodies to ornithobacterium rhinotracheale |
| 09/05/2000 | US6114109 Viral (HIV) growth inhibition |
| 09/05/2000 | US6113917 Genetic polypeptides added to ceramide based lipid-glycan anchor structure |